INFU on XASE, Health Care, InfuSystem Holdings, Inc., job postings
Measures activity, not value. Not investment advice.
Profit jumped 71% to $9.4M over 12 months while revenue grew only 2.4%.
GoodInstitutional holders rose 16% to 116 filers in one quarter
Written by AI from the data on this page, 22 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
Industry
Surgical & medical instruments & apparatus (Health Care)
expected around 23 Feb 2027 (an estimate: a year ago it reported on 24 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $37.6M, net income $3.2M.
31 Dec 2021RevenueNet incomeNet losstallest bar $37.6M30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$37.6M
$3.2M
30 Jun 2026
$36.9M
$3.2M
31 Mar 2026
$33.7M
$1.0M
31 Dec 2025
$36.2M
$2.0M
30 Sep 2025
$36.5M
$2.3M
30 Jun 2025
$36.0M
$2.6M
31 Mar 2025
$34.7M
-$267K
31 Dec 2024
$33.8M
$933K
30 Sep 2024
$35.3M
$1.8M
30 Jun 2024
$33.7M
$717K
31 Mar 2024
$32.0M
-$1.1M
31 Dec 2023
$31.8M
$72K
30 Sep 2023
$31.9M
$689K
30 Jun 2023
$31.7M
$435K
31 Mar 2023
$30.4M
-$324K
31 Dec 2022
$28.8M
$107K
30 Sep 2022
$27.3M
$443K
30 Jun 2022
$27.0M
-$164K
31 Mar 2022
$26.8M
-$368K
31 Dec 2021
$26.5M
$387K
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$144.4M
$141.1M
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+2.4%
+13%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
$9.4M
$5.5M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
$0.44
$0.26
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
57.6%
55.4%
60.5%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
9.8%
7.7%
-8.3%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
6.5%
3.9%
-10.1%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
15.8%
-26.3%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
$24.8M
$24.3M
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$9.1M
$955K
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$19.7M
$20.9M
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
$10.6M
$20.0M
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
0.31
0.31
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$3.20
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
30.5
28.0
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
2.0
2.3
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
2.1
2.5
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
4.5
2.8
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
–
No data for this company
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+16%
116 13F filers vs 100
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
77%
15.5M shares held by 13F filers (30 Sep 2026) of 20.0M outstanding (8 Nov 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
3.4%
683K shares sold short (30 Oct 2026) of 20.0M outstanding (8 Nov 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
5.7
683K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
-16%
813K shares sold short in the report before, 683K on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
55%
55% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 43%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
–
We do not track this company's careers site yet.
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
We do not track this company's careers site yet.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
–
No data for this company
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
+3.0%
$37.6M vs $36.5M (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
–
No data for this company
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
$64K
the 12 months before: $95K
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
–
No data for this company
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
3
3 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
–
3 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.
Unusual now sharp changes in the last 90 days, compared with its own past
Short interest 813K, 5.6× a year earlier
Price $14.35 on 20 Nov 2026, +56% over 12 months (12-month range $7.42 to $15.28)
Sharp change
8-K and other filings
Lobbying filing
Insider net buying (open market). Insiders bought a net $150K in the last 12 months (the 12 months before: $21K).Revenue per quarter. Revenue $37.6M in the latest quarter, +3.0% on a year earlier.Capital spending per quarter. Capital spending $73K in the latest quarter, -7.6% on a year earlier.Institutional holders (13F filers). 116 13F filers reported holding it in the latest 13F quarter, +25% on a year earlier.Federal obligations. Federal obligations: $51K published in the last 12 months, -46% on the 12 months before.Lobbying spend. Lobbying spend: $0 published in the last 12 months.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, workers in warn layoff notices.
Quarter ended 31 Dec 2021: $26.5M, +7.3% on a year earlier; public on 16 Mar 2022
Quarter ended 31 Mar 2022: $26.8M, +9.4% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $27.0M, +8.9% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $27.3M, +2.7% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $28.8M, +8.7% on a year earlier; public on 17 Mar 2023
Quarter ended 31 Mar 2023: $30.4M, +13% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $31.7M, +17% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $31.9M, +17% on a year earlier; public on 10 Nov 2023
Quarter ended 31 Dec 2023: $31.8M, +10% on a year earlier; public on 11 Apr 2024
Quarter ended 31 Mar 2024: $32.0M, +5.4% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $33.7M, +6.2% on a year earlier; public on 10 Aug 2024
Quarter ended 30 Sep 2024: $35.3M, +11% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $33.8M, +6.5% on a year earlier; public on 12 Mar 2025
Quarter ended 31 Mar 2025: $34.7M, +8.5% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $36.0M, +6.8% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $36.5M, +3.3% on a year earlier; public on 5 Nov 2025
Quarter ended 31 Dec 2025: $36.2M, +7.0% on a year earlier; public on 28 Feb 2026
Quarter ended 31 Mar 2026: $33.7M, -3.0% on a year earlier; public on 9 May 2026
Quarter ended 30 Jun 2026: $36.9M, +2.6% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $37.6M, +3.0% on a year earlier; public on 10 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $373K, +63% on a year earlier; public on 16 Mar 2022
Quarter ended 31 Mar 2022: $178K, +29% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $158K, -19% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $235K, -14% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $411K, +10% on a year earlier; public on 17 Mar 2023
Quarter ended 31 Mar 2023: $317K, +78% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $177K, +12% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $122K, -48% on a year earlier; public on 10 Nov 2023
Quarter ended 31 Dec 2023: $408K, -0.7% on a year earlier; public on 11 Apr 2024
Quarter ended 31 Mar 2024: $182K, -43% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $337K, +90% on a year earlier; public on 10 Aug 2024
Quarter ended 30 Sep 2024: $43K, -65% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $530K, +30% on a year earlier; public on 12 Mar 2025
Quarter ended 31 Mar 2025: $131K, -28% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $217K, -36% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $79K, +84% on a year earlier; public on 5 Nov 2025
Quarter ended 31 Dec 2025: $133K, -75% on a year earlier; public on 28 Feb 2026
Quarter ended 31 Mar 2026: $157K, +20% on a year earlier; public on 9 May 2026
Quarter ended 30 Jun 2026: $91K, -58% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $73K, -7.6% on a year earlier; public on 10 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 74; public on 14 Feb 2022
31 Mar 2022 report: 76; public on 16 May 2022
30 Jun 2022 report: 66; public on 15 Aug 2022
30 Sep 2022 report: 58; public on 14 Nov 2022
31 Dec 2022 report: 63; public on 14 Feb 2023
31 Mar 2023 report: 60; public on 15 May 2023
30 Jun 2023 report: 60; public on 14 Aug 2023
30 Sep 2023 report: 63; public on 14 Nov 2023
31 Dec 2023 report: 57; public on 14 Feb 2024
31 Mar 2024 report: 64; public on 15 May 2024
30 Jun 2024 report: 74; public on 14 Aug 2024
30 Sep 2024 report: 76; public on 14 Nov 2024
31 Dec 2024 report: 85; public on 14 Feb 2025
31 Mar 2025 report: 92; public on 15 May 2025
30 Jun 2025 report: 89; public on 14 Aug 2025
30 Sep 2025 report: 93; public on 14 Nov 2025
31 Dec 2025 report: 98; public on 17 Feb 2026
31 Mar 2026 report: 95; public on 15 May 2026
30 Jun 2026 report: 100; public on 14 Aug 2026
30 Sep 2026 report: 116; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $4K published
Month from 1 Jan 2022: $3K published
Month from 1 Feb 2022: $5K published
Month from 1 Mar 2022: -$357 published
Month from 1 May 2022: $96K published
Month from 1 Jul 2022: $30K published
Month from 1 Aug 2022: $2K published
Month from 1 Sep 2022: -$95 published
Month from 1 Oct 2022: $34K published
Month from 1 Nov 2022: -$5K published
Month from 1 Dec 2022: $19K published
Month from 1 Jan 2023: -$1K published
Month from 1 Mar 2023: $25K published
Month from 1 Apr 2023: $25K published
Month from 1 Aug 2023: $4K published
Month from 1 Sep 2023: $24K published
Month from 1 Oct 2023: $30K published
Month from 1 Nov 2023: -$12K published
Month from 1 Dec 2023: $2K published
Month from 1 Jan 2024: $3K published
Month from 1 Feb 2024: $2K published
Month from 1 Mar 2024: $30K published
Month from 1 Apr 2024: $26K published
Month from 1 May 2024: $8K published
Month from 1 Jul 2024: $856 published
Month from 1 Aug 2024: $2K published
Month from 1 Sep 2024: -$2K published
Month from 1 Oct 2024: $42K published
Month from 1 Nov 2024: -$120 published
Month from 1 Jan 2025: $6K published
Month from 1 Feb 2025: $25K published
Month from 1 Mar 2025: $13K published
Month from 1 May 2025: $25K published
Month from 1 Jun 2025: -$17K published
Month from 1 Jul 2025: $2K published
Month from 1 Sep 2025: $18K published
Month from 1 Oct 2025: $22K published
Month from 1 Mar 2026: $25K published
Month from 1 Apr 2026: -$897 published
Month from 1 Jun 2026: $0 published
Month from 1 Jul 2026: $0 published
Month from 1 Oct 2026: $27K published
Lobbying spend
Quarter from 1 Jan 2022: $20K published
Quarter from 1 Apr 2022: $20K published
Quarter from 1 Jul 2022: $20K published
Quarter from 1 Oct 2022: $10K published
What is unusual now
Made public in the last 90 days: it had 813K shares sold short in the 15 Oct 2026 report, 5.6× the same report last year; it also had 864K shares sold short in the 30 Sep 2026 report, 3.5× the same report last year. 6 sharp changes in all.
Short interest spike: had 813K shares sold short in the 15 Oct 2026 report, 5.6× the same report last year Public on 27 Oct 2026.
Reported lobbying spend: $10K in Q3 2022, $20K in Q2 2022. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
Date
Change
Lobbying firm
Issue
Source
31 Aug 2022
Ended
Tiber Creek Groupfor Infusystems Holdings, Inc.
Issues related to Medicare reimbursement for opioid alternative treatments, including H.R. 3259 & S. 586 - NOPAIN Act.Medicare/Medicaid
Two or more unrelated kinds of records unusual within 30 days
26 Mar 2019confirmed
Confirmed across sources Insiders and Filings + Financials
InfuSystem(INFU): had 3 insiders buy $175K of its shares on the open market within 30 days (3 filings), while it reported revenue of $3.2M for the quarter ended 31 Dec 2018, 83% below the same quarter last year. Two unrelated kinds of activity within 4 days.
Insiders: Clustered insider buying, became public on 22 Mar 2019
Financials: Quarterly revenue change, became public on 26 Mar 2019
The quarter ended 31 Dec 2018 against the 8 quarters before it.
this quarterearliernormal: $17.1MSee the evidence (2 changes)
Insiders: Clustered insider buying became public on 22 Mar 2019
InfuSystem had 3 insiders buy $175K of its shares on the open market within 30 days (3 filings).
Independent buyers
3
Purchase filings (Form 4, code P)
3
Total bought
$175K
Window
20 Feb 2019 to 22 Mar 2019
Dilorio Richard (President & CEO) bought 3,900 shares of INFU ($16,458)dated 13 Mar 2019, public 14 Mar 2019
Sansone Christopher R. (director) bought 25,000 shares of INFU ($109,000)dated 19 Mar 2019, public 20 Mar 2019
Shuda Scott (director) bought 11,224 shares of INFU ($49,065)dated 21 Mar 2019, public 22 Mar 2019
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
Financials: Quarterly revenue change became public on 26 Mar 2019
InfuSystem reported revenue of $3.2M for the quarter ended 31 Dec 2018, 83% below the same quarter last year.
This period
$3.2M (the quarter ended 31 Dec 2018)
Normal quarter (median of 8 earlier)
$17.1M
Typical spread (median absolute deviation)
$1.2M
How far from its usual level
-7.9
Same quarter last year
$18.9M
History used
3,106 days
the quarter ended 31 Dec 20188 earlier quartersnormal: $17.1M
Fires when the period is at least 3.0 robust standard deviations away from the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
Timeline
Changes and notable records, by the date each became public
11 Nov 2026Short interest and volume change
had 683K shares sold short in the 30 Oct 2026 report, 4.5× the same report last year.
Same report last year: 153K; its normal report is 190K.
See the evidence
This period
683K (the 30 Oct 2026 report)
Normal report (median of 24 earlier)
190K
Typical spread (median absolute deviation)
49K
How far from its usual level
+6.8
Same report last year
153K
History used
3,227 days
the 30 Oct 2026 report24 earlier reportsnormal: 190K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 813K shares sold short in the 15 Oct 2026 report, 5.6× the same report last year.
Same report last year: 146K; its normal report is 179K.
See the evidence
This period
813K (the 15 Oct 2026 report)
Normal report (median of 24 earlier)
179K
Typical spread (median absolute deviation)
35K
How far from its usual level
+12.1
Same report last year
146K
History used
3,212 days
the 15 Oct 2026 report24 earlier reportsnormal: 179K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 864K shares sold short in the 30 Sep 2026 report, 3.5× the same report last year.
Same report last year: 245K; its normal report is 179K.
See the evidence
This period
864K (the 30 Sep 2026 report)
Normal report (median of 24 earlier)
179K
Typical spread (median absolute deviation)
35K
How far from its usual level
+13.1
Same report last year
245K
History used
3,197 days
the 30 Sep 2026 report24 earlier reportsnormal: 179K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 812K shares sold short in the 15 Sep 2026 report, 5.7× the same report last year.
Same report last year: 143K; its normal report is 172K.
See the evidence
This period
812K (the 15 Sep 2026 report)
Normal report (median of 24 earlier)
172K
Typical spread (median absolute deviation)
36K
How far from its usual level
+12.0
Same report last year
143K
History used
3,182 days
the 15 Sep 2026 report24 earlier reportsnormal: 172K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 755K shares sold short in the 31 Aug 2026 report, 4.6× the same report last year.
Same report last year: 164K; its normal report is 169K.
See the evidence
This period
755K (the 31 Aug 2026 report)
Normal report (median of 24 earlier)
169K
Typical spread (median absolute deviation)
29K
How far from its usual level
+11.7
Same report last year
164K
History used
3,167 days
the 31 Aug 2026 report24 earlier reportsnormal: 169K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 734K shares sold short in the 14 Aug 2026 report, 4.6× the same report last year.
Same report last year: 161K; its normal report is 165K.
See the evidence
This period
734K (the 14 Aug 2026 report)
Normal report (median of 24 earlier)
165K
Typical spread (median absolute deviation)
25K
How far from its usual level
+11.4
Same report last year
161K
History used
3,150 days
the 14 Aug 2026 report24 earlier reportsnormal: 165K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 781K shares sold short in the 31 Jul 2026 report, 5.5× the same report last year.
Same report last year: 142K; its normal report is 162K.
See the evidence
This period
781K (the 31 Jul 2026 report)
Normal report (median of 24 earlier)
162K
Typical spread (median absolute deviation)
22K
How far from its usual level
+12.4
Same report last year
142K
History used
3,136 days
the 31 Jul 2026 report24 earlier reportsnormal: 162K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 3 insiders buy $131K of its shares on the open market within 30 days (3 filings).
Who bought: Steele Barry G, Gendron Paul Andrew, Lachance Carrie.
See the evidence (3 source records)
Independent buyers
3
Purchase filings (Form 4, code P)
3
Total bought
$131K
Window
13 Apr 2026 to 13 May 2026
Steele Barry G (Executive VP and CFO) bought 7,000 shares of INFU ($60,970)dated 12 May 2026, public 13 May 2026
GENDRON PAUL ANDREW (director) bought 5,000 shares of INFU ($44,400)dated 12 May 2026, public 13 May 2026
Lachance Carrie (President and CEO) bought 3,000 shares of INFU ($26,120)dated 12 May 2026, public 13 May 2026
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
had 606K shares sold short in the 13 Jun 2025 report, 4.3× the same report last year.
Same report last year: 142K; its normal report is 171K.
See the evidence
This period
606K (the 13 Jun 2025 report)
Normal report (median of 24 earlier)
171K
Typical spread (median absolute deviation)
15K
How far from its usual level
+8.7
Same report last year
142K
History used
2,723 days
the 13 Jun 2025 report24 earlier reportsnormal: 171K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 508K shares sold short in the 30 May 2025 report, 3.6× the same report last year.
Same report last year: 142K; its normal report is 170K.
See the evidence
This period
508K (the 30 May 2025 report)
Normal report (median of 24 earlier)
170K
Typical spread (median absolute deviation)
15K
How far from its usual level
+6.8
Same report last year
142K
History used
2,709 days
the 30 May 2025 report24 earlier reportsnormal: 170K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 6 insiders buy $123K of its shares on the open market within 30 days (6 filings).
Who bought: Chupa Addam, Gendron Paul Andrew, Steele Barry G, Funke Jerod and 2 more.
See the evidence (6 source records)
Independent buyers
6
Purchase filings (Form 4, code P)
6
Total bought
$123K
Window
24 Apr 2024 to 24 May 2024
Chupa Addam (Executive VP and CIO) bought 1,000 shares of INFU ($6,670)dated 21 May 2024, public 22 May 2024
GENDRON PAUL ANDREW (director) bought 5,000 shares of INFU ($32,700)dated 21 May 2024, public 22 May 2024
Steele Barry G (Executive VP and CFO) bought 3,000 shares of INFU ($19,410)dated 21 May 2024, public 22 May 2024
Funke Jerod (EVP-Chief HR Officer) bought 1,000 shares of INFU ($6,390)dated 21 May 2024, public 22 May 2024
BOYD RALPH F JR (director) bought 4,000 shares of INFU ($28,520)dated 23 May 2024, public 24 May 2024
HUSS BEVERLY A (director) bought 4,300 shares of INFU ($29,498)dated 23 May 2024, public 24 May 2024
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
Showing the newest 40 of 150 entries; narrow the window or the kind of data to see older ones.
Not listed: 158 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001337013
Ticker
INFU
Domain
infusystem.com
Hq location
MI|ROCHESTER HILLS|48309 (1 unverified)
Lobbying client
infusystem, infusystems holdings
Name
Document, EX-21.1, HAPC, Inc., Healthcare Acquisition Partners Corp. and 3 more
Uei
Q9FQBS8UMU64, QDSNXMCN6E75
Federal lobbying disclosures (LDA)6 records, 66 data points1 Jun 2015 to 30 Sep 2022
SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)154 records21 Jan 2016 to 9 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)1064 data points31 Dec 2008 to 8 Nov 2026
SEC Form 4 insider transactions122 records, 416 data points6 Sep 2016 to 12 May 2026
FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)4150 data points1 Aug 2018 to 20 Nov 2026
USASpending.gov federal awards393 data points7 Jan 2009 to 7 Oct 2026